Face and Content validity of Persian version of Parkinson Fatigue Scale (PFS-16) in people with Parkinson’s disease

Document Type : Original article

Authors

1 Students` Research Office, MSc Student in Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Assistant Professor, PhD in Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Lecturer, MSc in occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Phd Student in Neurocognition, MSc in Occupational Therapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 PhD in Biostatistics, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background and Aim: Parkinson’s disease (PD) is the second common neuro-degenerative disorder after Alzheimer’s disease (AD). Tremor at rest, rigidity, bradykinesia, and postural control impairments are the four main diagnostic symptoms of PD. However, people with PD reported several non-motor symptoms. Among non-motor symptoms, fatigue is the most widespread with the prevalence rates of 40-65 percent that can have impacts on the quality of life of these people. The purpose of the present study was to translate and evaluate face and content validity of Parkinson Fatigue Scale (PFS-16) in patients with Parkinson's.
Materials and Method: Translation of this scale was done in two phases according to international quality of life assessment (IQOLA). Then, face validity was checked by 15 patients with Parkinson's disease and content validity was evaluated by 15 occupational therapists. To determine the content validity ratio (CVR) and content validity index (CVI), Lawshe’s method was used.
Results: In the translation phase, only one question was changed because of conceptual problem. Face validity was very high for this measure. According to Lawshe, content validity ratio (CVR) and content validity index (CVI) were in the acceptable range.
Conclusion: Persian version of Parkinson Fatigue Scale (PFS-16) has high face and content validity which is good for assessing fatigue in people with Parkinson's.
 
Key words:

Keywords

Main Subjects


1. Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson's disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2009;1792(7):643-50.##
2. Pendleton HM, Schultz-Krohn W. Pedretti's occupational therapy: practice skills for physical dysfunction: Elsevier Health Sciences; 2013.##
3. Swanson CR, Sesso SL, Emborg ME. Can we prevent Parkinson's disease? Frontiers in bioscience (Landmark edition). 2008;14:1642-60.##
4. De Rijk M, Launer L, Berger K, Breteler M, Dartigues J, Baldereschi M, et al. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 1999;54(11 Suppl 5): 21-23.##
5. Fereshtehnejad S-M, Naderi N, Rahmani A, Shahidi GA, Delbari A, Lökk J. Psychometric study of the Persian short-form eight-item Parkinson’s disease questionnaire (PDQ-8) to evaluate health related quality of life (HRQoL). Health and quality of life outcomes. 2014;12(1):1-9.##
6. Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez‐Martin P, et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Movement Disorders. 2010;25(7):805-22.##
7. Hagell P, Höglund A, Reimer J, Eriksson B, Knutsson I, Widner H, et al. Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires. Journal of pain and symptom management. 2006;32(5):420-32.##
8. Schiehser DM, Ayers CR, Liu L, Lessig S, Song DS, Filoteo JV. Validation of the modified fatigue impact scale in Parkinson’s disease. Parkinsonism & related disorders. 2013;19(3):335-38.##
9. Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z, et al. Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. Parkinsonism & related disorders. 2008;14(3):187-92.##
10. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's disease–the fatigue severity scale. European Journal of Neurology. 2002;9(6):595-600.##
11. Brown R, Dittner A, Findley L, Wessely S. The Parkinson fatigue scale. Parkinsonism & related disorders.2005;11(10):49-55.##
12. Falup-Pecurariu C. Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic. Journal of Neural Transmission. 2013;120(4):577-81.##
13. Grace J, Mendelsohn A, Friedman JH. A comparison of fatigue measures in Parkinson's disease. Parkinsonism & related disorders. 2007;13(7):443-45.##
14. Hagell P, Rosblom T, Pålhagen S. A Swedish version of the 16‐item Parkinson fatigue scale (PFS‐16). Acta Neurologica Scandinavica. 2012;125(4):288-92.##
15. Kummer A, Scalzo P, Cardoso F, Teixeira AL. Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale. Acta Neurologica Scandinavica. 2011;123(2):130-36.##
16. Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, et al. Fatigue in Japanese patients with Parkinson's disease: a study using Parkinson fatigue scale. Movement Disorders. 2009;24(13):1977-83.##
17. Ayre C, Scally AJ. Critical Values for Lawshe’s Content Validity Ratio Revisiting the Original Methods of Calculation. Measurement and Evaluation in Counseling and Development. 2014;47(1):79-86.##
18. Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, et al. Fatigue in Parkinson's disease: a review. Movement Disorders. 2007;22(3):297-308.##
Volume 5, Issue 1
March and April 2016
Pages 85-92
  • Receive Date: 12 July 2015
  • Revise Date: 02 August 2015
  • Accept Date: 14 October 2015
  • First Publish Date: 20 March 2016